Alere™ q HIV-1/2 Detect
A child born today to an HIV positive mother faces great challenges in reaching their first birthday. HIV diagnosis in infants is difficult as common antibody tests are ineffective.
According to a recent joint WHO/UNAIDS/UNICEF report, an estimated 72 percent of children born to HIV-positive mothers remain untested for HIV before the age of 8 weeks.
With Alere™ q HIV-1/2 Detect we can now test at the point of care with accurate molecular results in under an hour. This allows clinicians to start infants on antiretroviral therapy well within recommended guidelines.